1. WHO | Hepatitis B [Internet]. WHO. [cited 2015 Nov 30]. Available from: http://www.who.int/mediacentre/factsheets/fs204_Jul2014/en/
2. European Association For The Study Of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167-185.
3. Celen MK, Mert D, Ay M, Dal T, Kaya S, Yildirim N, Gulsun S, Barcin T, Kalkanli S, Dal MS, Ayaz C. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. World J Gastroenterol. 2013;19:9377-9382.
4. Tekin Koruk S, Batirel A, Kose S, Cetin Akhan S, Aygen B, Tulek N, Hatipoglu C, Bulut C, Yıldız O, Sacligil C, Sirmatel F, Altunok E. Evaluation of hepatitis B virus transmission and antiviral therapy among hepatitis B surface antigen-positive pregnant women. J Obstet Gynaecol Res. 2015;41:1870-1876.
5. Ertürk A, Cüre E, Parlak E, Cüre MC, Çapur Çİçek A, Kır Şahin F. Evaluation of the Results of Antiviral Therapy in Pregnant Women with Chronic Hepatitis B. Viral Hepatits J. 2014;20:23-27.
6. Ahn J, Salem SB, Cohen SM. Evaluation and management of hepatitis B in pregnancy: a survey of current practices. Gastroenterol Hepatol (N Y). 2010;6:570-578.
7. Giles ML, Garland SM, Grover SR, Lewin SM, Hellard ME. Impact of an education campaign on management in pregnancy of women infected with a blood-borne virus. Med J Aust. 2006;184:389-392.
8. de Oliveira PR, Yamamoto AY, de Souza CB, de Araújo NM, de Andrade Gomes S, Heck AR, de Castro Figueiredo JF, Mussi-Pinhata MM. Hepatitis B viral markers in banked human milk before and after Holder pasteurization. J Clin Virol. 2009;45:281-284.
9. Chen X, Chen J, Wen J, Xu C, Zhang S, Zhou YH, Hu Y. Breastfeeding is not a risk factor for mother-to-child transmission of hepatitis B virus. PloS One. 2013;8:55303.
10. Shi Z, Yang Y, Wang H, Ma L, Schreiber A, Li X, Sun W, Zhao X, Yang X, Zhang L, Lu W, Teng J, An Y. Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch Pediatr Adolesc Med. 2011;165:837-846.
11. Zheng Y, Lu Y, Ye Q, Xia Y, Zhou Y, Yao Q, Wei S. Should chronic hepatitis B mothers breastfeed? a meta analysis. BMC Public Health. 2011;11:502.
12. Hirnschall G, Harries AD, Easterbrook PJ, Doherty MC, Ball A. The next generation of the World Health Organization’s global antiretroviral guidance. J Int AIDS Soc. 2013;16:18757.
13. Xu W-M, Cui Y-T, Wang L, Yang H, Liang Z-Q, Li X-M, Zhang SL, QİAO FY, Campbell F, Chang CN, Gardner S, Atkins M. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. Viral Hepatitis J. 2009;16:94-103.
14. Lamivudine Use During Pregnancy | Drugs.com [Internet]. [cited 2016 Mar 20]. Available from: http://www.drugs.com/pregnancy/lamivudine.html
15. FDA Pregnancy Categories A, B, C, D, X, N Explained [Internet]. [cited 2016 Mar 20]. Available from: http://www.drugs.com/pregnancy-categories.html
16. APR [Internet]. WHO. [cited 2015 Dec 17]. Available from: http://www.apregistry.com/InterimReport.aspx
17. Mirochnick M, Thomas T, Capparelli E, Zeh C, Holland D, Masaba R, Odhiambo P, Fowler MG, Weidle PJ, Thigpen MC. Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy. Antimicrob Agents Chemother. 2009;53:1170-1176.
18. Giuliano M, Guidotti G, Andreotti M, Pirillo MF, Villani P, Liotta G, Marazzi MC, Mancini MG, Cusato M, Germano P,Loureiro S, Ceffa S, Regazzi M, Vella S, Palombi L. Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program. J Acquir Immune Defic Syndr. 2007;44:286-291.
19. Shapiro RL, Holland DT, Capparelli E, Lockman S, Thior I, Wester C, Stevens L, Peter T, Essex M, Connor JD,Mirochnick M. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. J Infect Dis. 2005;192:720-727.
20. Tenofovir (Viread) Use During Pregnancy [Internet]. [cited 2016 Mar 20]. Available from: http://www.drugs.com/pregnancy/tenofovir.html
21. Benaboud S, Pruvost A, Coffie PA, Ekouévi DK, Urien S, Arrivé E, Blanche S, Théodoro F, Avit D, Dabis F, Tréluyer JM, Hirt D. Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d’Ivoire, in the ANRS 12109 TEmAA Study, Step 2. Antimicrob Agents Chemother. 2011;55:1315-1317.
22. Van Rompay KK, Hamilton M, Kearney B, Bischofberger N. Pharmacokinetics of tenofovir in breast milk of lactating rhesus macaques. Antimicrob Agents Chemother. 2005;49:2093-2094.
23. Palombi L, Pirillo MF, Marchei E, Jere H, Sagno JB, Luhanga R, Floridia M, Andreotti M, Galluzzo CM, Pichini S, Mwenda R, Mancinelli S, Marazzi MC, Vella S, Liotta G, Giuliano M. Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi. J Antimicrob Chemother. 2016;71:1027-1030.
24. Siberry GK, Jacobson DL, Kalkwarf HJ, Wu JW, DiMeglio LA, Yogev R, Knapp KM, Wheeler JJ, Butler L,Hazra R, Miller TL, Seage GR 3rd, Van Dyke RB, Barr E, Davtyan M, Mofenson LM, Rich KC, Pediatric HIV/AIDS Cohort Study. Lower newborn bone mineral content associated with maternal use of tenofovir disoproxil fumarate during pregnancy. Clin Infect Dis. 2015;61:996-1003.
25. Pons JC, Lebon P, Frydman R, Delfraissy JF. Pharmacokinetics of interferon-alpha in pregnant women and fetoplacental passage. Fetal DiagnTher. 1995;10:7-10.
26. Kumar AR, Hale TW, Mock RE. Transfer of interferon alfa into human breast milk. J Hum Lact. 2000;16:226-228.
27. toxnet [Internet]. Available from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+lactmed:@[email protected]+148
28. Adefovir (Hepsera) Use During Pregnancy [Internet]. [cited 2016 Mar 20]. Available from: http://www.drugs.com/pregnancy/adefovir.html
29. Entecavir (Baraclude) Use During Pregnancy [Internet]. [cited 2016 Mar 20]. Available from: http://www.drugs.com/pregnancy/entecavir.html
30. Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, Yue X, Wang GJ, Tang X, Fang ZX. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol. 2011;55:1215-1221.
31. Telbivudine (Tyzeka) Use During Pregnancy [Internet]. [cited 2016 Mar 20]. Available from: http://www.drugs.com/pregnancy/telbivudine.html
32. Gerada J, Borg E, Formosa D, Magro R, Pocock J. Tenofovir as rescue therapy following clinical failure to Lamivudine in severe acute hepatitis B. Mediterr J Hematol Infect Dis. 2013;5:2013035.
33. Montoya-Ferrer A, Zorrilla AM, Viljoen J, Molès JP, Newell ML, Van de Perre P, Tuaillon E. High level of HBV DNA virus in the breast milk seems not to contraindicate breastfeeding. Mediterr J Hematol Infect Dis. 2015;7:2015042.
34. Ehrhardt S, Xie C, Guo N, Nelson K, Thio CL. Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence. Clin Infect Dis. 2015;60:275-278.